Literature DB >> 26916438

Isopimarane diterpenoids from Kaempferia pulchra rhizomes collected in Myanmar and their Vpr inhibitory activity.

Nwet Nwet Win1, Takuya Ito2, Takashi Matsui2, Simayijiang Aimaiti2, Takeshi Kodama2, Hla Ngwe3, Yasuko Okamoto4, Masami Tanaka4, Yoshinori Asakawa4, Ikuro Abe5, Hiroyuki Morita2.   

Abstract

Viral protein R (Vpr), an accessory gene of HIV-1, plays important roles in viral pathogenesis. Screening of Myanmar medicinal plants that are popular as primary treatments for HIV/AIDS and for HIV-related problems revealed the potent anti-Vpr activity of the CHCl3-soluble extract of Kaempferia pulchra rhizomes, in comparison with that of the positive control, damnacanthal. Fractionation of the active CHCl3-soluble extract led to the identification of 30 isopimarane diterpenoids, including kaempulchraols A-W (1-23). All isolates were assayed for anti-Vpr activity against TREx-HeLa-Vpr cells, in which Vpr expression is tightly regulated by tetracycline. Kaempulchraols B (2), D (4), G (7), Q (17), T (20), U (21), and W (23) exhibited potent anti-Vpr activity, at concentrations ranging from 1.56 to 6.25μM. The structure-activity relationships of the active kaempulchraols suggested that the presence of a hydroxy group at C-14 in an isopimara-8(9),15-diene skeleton and the presence of an acetoxy group at C-1 or C-7 in an isopimara-8(14),15-diene skeleton are the critical factors for the inhibitory effects against TREx-HeLa-Vpr cells.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-Vpr; Kaempferia pulchra; Kaempulchraols; TREx-HeLa-Vpr cells

Mesh:

Substances:

Year:  2016        PMID: 26916438     DOI: 10.1016/j.bmcl.2016.02.036

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

1.  Bioactive Compounds from Medicinal Plants in Myanmar.

Authors:  Nwet Nwet Win; Hiroyuki Morita
Journal:  Prog Chem Org Nat Prod       Date:  2021

2.  Anti-Vpr activities of sesqui- and diterpenoids from the roots and rhizomes of Kaempferia candida.

Authors:  Takeshi Kodama; Hnin Htet Wai Nyunt; Hla Ngwe; Ikuro Abe; Hiroyuki Morita
Journal:  J Nat Med       Date:  2021-03-09       Impact factor: 2.343

Review 3.  The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention.

Authors:  María Eugenia González
Journal:  Int J Mol Sci       Date:  2017-01-10       Impact factor: 5.923

Review 4.  Naturally occurring Vpr inhibitors from medicinal plants of Myanmar.

Authors:  Nwet Nwet Win; Hla Ngwe; Ikuro Abe; Hiroyuki Morita
Journal:  J Nat Med       Date:  2017-07-05       Impact factor: 2.343

Review 5.  Recent Advances in Kaempferia Phytochemistry and Biological Activity: A Comprehensive Review.

Authors:  Abdelsamed I Elshamy; Tarik A Mohamed; Ahmed F Essa; Ahmed M Abd-ElGawad; Ali S Alqahtani; Abdelaaty A Shahat; Tatsuro Yoneyama; Abdel Razik H Farrag; Masaaki Noji; Hesham R El-Seedi; Akemi Umeyama; Paul W Paré; Mohamed-Elamir F Hegazy
Journal:  Nutrients       Date:  2019-10-07       Impact factor: 5.717

Review 6.  Structure-Activity-Relationship and Mechanistic Insights for Anti-HIV Natural Products.

Authors:  Ramandeep Kaur; Pooja Sharma; Girish K Gupta; Fidele Ntie-Kang; Dinesh Kumar
Journal:  Molecules       Date:  2020-04-29       Impact factor: 4.411

7.  Impact of HIV-1 Vpr manipulation of the DNA repair enzyme UNG2 on B lymphocyte class switch recombination.

Authors:  Patrick Eldin; Sophie Péron; Anastasia Galashevskaya; Nicolas Denis-Lagache; Michel Cogné; Geir Slupphaug; Laurence Briant
Journal:  J Transl Med       Date:  2020-08-10       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.